These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7447102)

  • 1. Massive intravenous bolus bretylium tosylate.
    Bodnar T; Nowak R; Tomlanovich MC
    Ann Emerg Med; 1980 Dec; 9(12):630-3. PubMed ID: 7447102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical ventricular tachycardia and fibrillation after intravenous bretylium therapy. Report of two cases.
    Anderson JL; Popat KD; Pitt B
    Arch Intern Med; 1981 May; 141(6):801-2. PubMed ID: 7235792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of refractory ventricular arrhythmias. High dose parenteral and oral bretylium tosylate.
    Noneman JW; Batenhorst RL; Jones MR; Garrett ER; Foster TS
    Chest; 1982 Apr; 81(4):517-9. PubMed ID: 7067521
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of refractory ventricular tachycardia and fibrillation by bretylium tosylate: a report of 4 cases].
    Li SZ; Xu XH
    Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Aug; 15(4):203-4, 12. PubMed ID: 3440418
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful long-term suppression of previously refractory paroxysmal ventricular tachycardia with bretylium tosylate.
    Slack JD; Rizk AE; Wright KE
    Heart Lung; 1979; 8(4):721-7. PubMed ID: 378903
    [No Abstract]   [Full Text] [Related]  

  • 6. Electrophysiologic testing of bretylium tosylate in sustained ventricular tachycardia.
    Bauernfeind RA; Hoff JV; Swiryn S; Palileo E; Strasberg B; Scagliotti D; Rosen KM
    Am Heart J; 1983 Jun; 105(6):973-80. PubMed ID: 6858846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bretylium tosylate as initial treatment for cardiopulmonary arrest: randomized comparison with placebo.
    Nowak RM; Bodnar TJ; Dronen S; Gentzkow G; Tomlanovich MC
    Ann Emerg Med; 1981 Aug; 10(8):404-7. PubMed ID: 7258754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of intravenous and oral bretylium tosylate in survivors of ventricular tachycardia or fibrillation: clinical application of a new assay for bretylium.
    Anderson JL; Patterson E; Wagner JG; Johnson TA; Lucchesi BR; Pitt B
    J Cardiovasc Pharmacol; 1981; 3(3):485-99. PubMed ID: 6168830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.
    Heissenbuttel RH; Bigger JT
    Ann Intern Med; 1979 Aug; 91(2):229-38. PubMed ID: 380436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group.
    Kowey PR; Levine JH; Herre JM; Pacifico A; Lindsay BD; Plumb VJ; Janosik DL; Kopelman HA; Scheinman MM
    Circulation; 1995 Dec; 92(11):3255-63. PubMed ID: 7586312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bretylium tosylate and hypothermic ventricular fibrillation.
    Dronen S; Nowak RM; Tomlanovich MC
    Ann Emerg Med; 1980 Jun; 9(6):335. PubMed ID: 7386965
    [No Abstract]   [Full Text] [Related]  

  • 13. Profound hypotension following a "test dose" of bretylium tosylate.
    Alfery DD; Denlinger JK
    Anesth Analg; 1979; 58(6):516-8. PubMed ID: 574738
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe hypotension due to the use of bretylium for postcardiotomy ventricular arrhythmias.
    Kron IL; Nolan SP
    Ann Thorac Surg; 1983 Mar; 35(3):271-3. PubMed ID: 6600915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction.
    Dhurandhar RW; Pickron J; Goldman AM
    Heart Lung; 1980; 9(2):265-70. PubMed ID: 6898604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of bretylium tosylate for ventricular tachycardia.
    Chandrasekaran S; Steinberg JS
    Am J Cardiol; 1999 Jan; 83(1):115-7, A9. PubMed ID: 10073797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of bretylium to suppress inducible ventricular tachycardia.
    Greene HL; Werner JA; Gross BW; Sears GK
    Am Heart J; 1983 May; 105(5):717-21. PubMed ID: 6846114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bretylium tosylate in patients with acute myocardial infarction.
    Torresani J
    Am J Cardiol; 1984 Jul; 54(2):20A-25A. PubMed ID: 6464996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deleterious effects of bretylium on hemodynamic recovery from ventricular fibrillation.
    Euler DE; Zeman TW; Wallock ME; Scanlon PJ
    Am Heart J; 1986 Jul; 112(1):25-31. PubMed ID: 3728284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of bretylium in prehospital ventricular fibrillation.
    Harrison EE; Amey BD
    Am J Emerg Med; 1983 Jul; 1(1):1-6. PubMed ID: 6680596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.